$KITE Kite Pharma, Inc. Insider Trading Week 20/2015
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in Kite Pharma, Inc..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in Kite Pharma, Inc. in week 20/2015.
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
May 19 2015 | KITE | Kite Pharma, Inc. | Roberts Margo R | Chief Scientific Of ... | Option Exercise | M | 0.70 | 8,625 | 6,038 | 141,375 | |
May 19 2015 | KITE | Kite Pharma, Inc. | Roberts Margo R | Chief Scientific Of ... | Sell | S | 52.22 | 130 | 6,789 | 999 | 1.1 K to 999 (-11.51 %) |
May 19 2015 | KITE | Kite Pharma, Inc. | Roberts Margo R | Chief Scientific Of ... | Sell | S | 51.59 | 1,674 | 86,362 | 1,129 | 2.8 K to 1.1 K (-59.72 %) |
May 19 2015 | KITE | Kite Pharma, Inc. | Roberts Margo R | Chief Scientific Of ... | Sell | S | 50.42 | 2,330 | 117,479 | 2,803 | 5.1 K to 2.8 K (-45.39 %) |
May 19 2015 | KITE | Kite Pharma, Inc. | Roberts Margo R | Chief Scientific Of ... | Sell | S | 49.45 | 4,491 | 222,080 | 5,133 | 9.6 K to 5.1 K (-46.66 %) |
May 19 2015 | KITE | Kite Pharma, Inc. | Roberts Margo R | Chief Scientific Of ... | Buy | M | 0.70 | 8,625 | 6,038 | 9,624 | 999 to 9.6 K (+863.36 %) |
May 19 2015 | KITE | Kite Pharma, Inc. | Wiezorek Jeffrey | VP Clinical Develop ... | Option Exercise | M | 6.89 | 9,000 | 62,010 | 166,000 | |
May 19 2015 | KITE | Kite Pharma, Inc. | Wiezorek Jeffrey | VP Clinical Develop ... | Sell | S | 52.21 | 128 | 6,683 | 1,218 | 1.3 K to 1.2 K (-9.51 %) |
May 19 2015 | KITE | Kite Pharma, Inc. | Wiezorek Jeffrey | VP Clinical Develop ... | Sell | S | 51.57 | 1,528 | 78,799 | 1,346 | 2.9 K to 1.3 K (-53.17 %) |
May 19 2015 | KITE | Kite Pharma, Inc. | Wiezorek Jeffrey | VP Clinical Develop ... | Sell | S | 50.49 | 2,638 | 133,193 | 2,874 | 5.5 K to 2.9 K (-47.86 %) |
May 19 2015 | KITE | Kite Pharma, Inc. | Wiezorek Jeffrey | VP Clinical Develop ... | Sell | S | 49.44 | 4,706 | 232,665 | 5,512 | 10.2 K to 5.5 K (-46.06 %) |
May 19 2015 | KITE | Kite Pharma, Inc. | Wiezorek Jeffrey | VP Clinical Develop ... | Buy | M | 6.89 | 9,000 | 62,010 | 10,218 | 1.2 K to 10.2 K (+738.92 %) |
May 19 2015 | KITE | Kite Pharma, Inc. | Sproule Rizwana F | VP Regulatory Affai ... | Option Exercise | M | 1.35 | 9,567 | 12,915 | 190,433 | |
May 19 2015 | KITE | Kite Pharma, Inc. | Sproule Rizwana F | VP Regulatory Affai ... | Sell | S | 52.21 | 30 | 1,566 | 1,695 | 1.7 K to 1.7 K (-1.74 %) |
May 19 2015 | KITE | Kite Pharma, Inc. | Sproule Rizwana F | VP Regulatory Affai ... | Sell | S | 51.63 | 1,813 | 93,605 | 1,725 | 3.5 K to 1.7 K (-51.24 %) |
May 19 2015 | KITE | Kite Pharma, Inc. | Sproule Rizwana F | VP Regulatory Affai ... | Sell | S | 50.49 | 2,538 | 128,144 | 3,538 | 6.1 K to 3.5 K (-41.77 %) |
May 19 2015 | KITE | Kite Pharma, Inc. | Sproule Rizwana F | VP Regulatory Affai ... | Sell | S | 49.47 | 5,186 | 256,551 | 6,076 | 11.3 K to 6.1 K (-46.05 %) |
May 19 2015 | KITE | Kite Pharma, Inc. | Sproule Rizwana F | VP Regulatory Affai ... | Buy | M | 1.35 | 9,567 | 12,915 | 11,262 | 1.7 K to 11.3 K (+564.42 %) |